Author

P. W. Hanley

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 5 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 6 Research Focus:host-pathogen & immune response· 6 Organism:non-human primate· 4 Research Focus:drug response / drug discovery· 3 Assay:bulk RNA-seq· 1 Organism:mouse· 1 Organism:rat· 1

Frequent Co-Authors

F. Feldmann· 5 shared J. Lovaglio· 4 shared A. Marzi· 3 shared A. Okumura· 3 shared H. Feldmann· 3 shared B. Kaza· 2 shared C. S. Clancy· 2 shared G. Saturday· 2 shared

Activity by Year

2021-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersMicrobiology

F. Feldmann

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

VSV-based vaccine provides species-specific protection against Sudan virus challenge in macaques

A. Marzi, P. Fletcher, F. Feldmann, G. Saturday, P. W. Hanley, H. Feldmann

This study develops a VSV-based vaccine against Sudan virus and shows it protects macaques from lethal infection, highlighting the need for specific countermeasures against filoviruses.

bioRxiv · Oct 27, 2022 · PreprintMicrobiology

Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-based vaccine

K. L. O'Donnell, F. Feldmann, B. Kaza, C. S. Clancy, P. W. Hanley, P. Fletcher, A. Marzi

A single low-dose VSV-based vaccine protects nonhuman primates from lethal Marburg virus disease regardless of administration timing.

bioRxiv · Sep 17, 2022Immunology

Severe acute respiratory disease in American mink (Neovison vison) experimentally infected with SARS-CoV-2

D. R. Adney, J. Lovaglio, J. E. Schulz, C. K. Yinda, V. A. Avanzato, E. Haddock, J. R. Port, M. Holbrook, P. W. Hanley, G. Saturday, D. Scott, J. R. Spengler, C. Tansey, C. Cossaboom, N. Wendling, , V. J. Munster

This study shows that SARS-CoV-2 infected mink develop severe respiratory disease with features similar to severe acute respiratory disease in humans.

bioRxiv · Jan 20, 2022 · PreprintMicrobiology

UK B.1.1.7 variant exhibits increased respiratory replication and shedding in nonhuman primates

K. Rosenke, F. Feldmann, A. Okumura, F. Hansen, T.-L. Tang-Huau, K. Meade-White, B. Kaza, B. J. Smith, P. W. Hanley, J. Lovaglio, M. Jarvis, C. Shaia, H. Feldmann

This study compares the respiratory replication and shedding of SARS-CoV-2 D614G and B.1.1.7 variants in African green monkeys, finding increased respiratory replication for B.1.1.7 but no disease enhancement.

bioRxiv · Jun 11, 2021Microbiology

A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques

A. O. Hassan, F. Feldmann, H. Zhao, D. T. Curiel, A. Okumura, T.-L. Tang-Huau, J. B. Case, K. Meade-White, J. Callison, J. Lovaglio, P. W. Hanley, D. P. Scott, D. H. Fremont, H. Feldmann, M. S. Diamond

A single intranasal dose of ChAd-SARS-CoV-2-S vaccine protects against SARS-CoV-2 infection in rhesus macaques by inducing neutralizing antibodies and T cell responses.

bioRxiv · Jan 26, 2021Microbiology

Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a recombinant vaccine

W. Furuyama, K. Shifflett, A. N. Pinksi, A. J. Griffin, F. Feldmann, A. Okumura, T. Gourdine, A. Jankeel, J. Lovaglio, P. W. Hanley, T. Thomas, C. S. Clancy, I. Messaoudi, K. L. O'Donnell, A. Marzi

A single-dose VSV-based vaccine protected nonhuman primates from COVID-19 within 10 days when administered intramuscularly but not intranasally.

bioRxiv · Jan 19, 2021 · PreprintMicrobiology